GT Biopharma annual ebitda
2014
2015
2016
2017
GT Biopharma EBITDA Growth & History (GTBP)
GT Biopharma's calculated EBITDA was −$135.6M for fiscal 2017.
View full GT Biopharma company overviewGT Biopharma annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2017 | 2017-12-31 | −$135.6M | −$126.2M | — |
| 2016 | 2016-12-31 | −$9.4M | −$448,000 | — |
| 2015 | 2015-12-31 | −$8.9M | −$6.6M | — |
| 2014 | 2014-12-31 | −$2.4M | — | — |
GT Biopharma quarterly ebitda
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q3.16
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2016 | 2016-09-30 | −$2.5M | −$719,000 | — |
| Q4 2015 | 2015-12-31 | −$2.9M | −$1.3M | — |
| Q3 2015 | 2015-09-30 | −$2.8M | −$2.2M | — |
| Q2 2015 | 2015-06-30 | −$1.4M | −$1.3M | — |
| Q1 2015 | 2015-03-31 | −$1.8M | −$1.7M | — |
| Q4 2014 | 2014-12-31 | −$1.6M | — | — |
| Q3 2014 | 2014-09-30 | −$549,000 | — | — |
| Q2 2014 | 2014-06-30 | −$103,000 | — | — |
| Q1 2014 | 2014-03-31 | −$100,000 | — | — |
GT Biopharma ebitda trends
Across the available reported history, GT Biopharma's ebitda decreased from −$9.4M to −$135.6M, a change of −$126.2M. The latest reported quarter, Q3 2016, shows −$2.5M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GT Biopharma filings at SEC.gov ↗